An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models

Melinda H MacDonald, Allen Y Wang, Jeffrey W Clymer, Richard W Hutchinson, Richard Kocharian Ethicon Inc., Somerville, NJ, USA Background: Usage of topical hemostatic agents in surgery is increasing, including use during minimally invasive procedures, and even for surgerie...

Full description

Bibliographic Details
Main Authors: MacDonald MH, Wang AY, Clymer JW, Hutchinson RW, Kocharian R
Format: Article
Language:English
Published: Dove Medical Press 2017-11-01
Series:Medical Devices: Evidence and Research
Subjects:
Online Access:https://www.dovepress.com/an-in-vivo-comparison-of-the-efficacy-of-hemostatic-powders-using-two--peer-reviewed-article-MDER
_version_ 1818346571111071744
author MacDonald MH
Wang AY
Clymer JW
Hutchinson RW
Kocharian R
author_facet MacDonald MH
Wang AY
Clymer JW
Hutchinson RW
Kocharian R
author_sort MacDonald MH
collection DOAJ
description Melinda H MacDonald, Allen Y Wang, Jeffrey W Clymer, Richard W Hutchinson, Richard Kocharian Ethicon Inc., Somerville, NJ, USA Background: Usage of topical hemostatic agents in surgery is increasing, including use during minimally invasive procedures, and even for surgeries that have a low risk of bleeding complications. A novel product, Surgicel® Powder – Absorbable Hemostatic Powder (SP), made from oxidized regenerated cellulose (ORC) fabric, has been developed for adjunctive use in surgical procedures to assist in control of oozing bleeding over broad areas and where access could be difficult with a fabric ORC product. This study compares the new SP to other commercially available hemostatic powder products in two in vivo models.Methods: Hemostatic efficacy of SP was compared to two polysaccharide-based hemostats in a porcine liver punch biopsy model and to three polysaccharide-based hemostats and one non-regenerated oxidized cellulose hemostat in a porcine liver abrasion model. Primary outcomes measured were hemostatic efficacy, defined as hemostasis within 10 minutes of application, and time-to-hemostasis (TTH).Results: In the punch biopsy model, SP displayed significantly higher effective hemostasis rates than one of the polysaccharide hemostats (p=0.047) and faster TTH than both (p<0.001). In the liver abrasion model, SP had significantly higher effective hemostasis rates (p≤0.002) and faster TTH (p<0.001) than the other four hemostatic agents. The amount of powder applied within the ranges used did not appear to affect hemostatic efficacy.Conclusion: In both the liver punch biopsy model of mild to moderate bleeding and the liver abrasion model of mild but diffuse oozing, SP provided more effective hemostasis and faster TTH than other marketed hemostatic powders. The results from this in vivo study suggest that Surgicel Powder may be useful in clinical applications where control of oozing capillary, mild venous, and small arterial hemorrhage is required including bleeding in difficult-to-access locations. Keywords: hemostasis, oxidized regenerated cellulose, Surgicel, in vivo model of bleeding, hemostatic powder, absorbable hemostat, topical absorbable hemostat
first_indexed 2024-12-13T17:20:23Z
format Article
id doaj.art-963f9f90023a46f3a2ee811954373d86
institution Directory Open Access Journal
issn 1179-1470
language English
last_indexed 2024-12-13T17:20:23Z
publishDate 2017-11-01
publisher Dove Medical Press
record_format Article
series Medical Devices: Evidence and Research
spelling doaj.art-963f9f90023a46f3a2ee811954373d862022-12-21T23:37:20ZengDove Medical PressMedical Devices: Evidence and Research1179-14702017-11-01Volume 1027327935798An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding modelsMacDonald MHWang AYClymer JWHutchinson RWKocharian RMelinda H MacDonald, Allen Y Wang, Jeffrey W Clymer, Richard W Hutchinson, Richard Kocharian Ethicon Inc., Somerville, NJ, USA Background: Usage of topical hemostatic agents in surgery is increasing, including use during minimally invasive procedures, and even for surgeries that have a low risk of bleeding complications. A novel product, Surgicel® Powder – Absorbable Hemostatic Powder (SP), made from oxidized regenerated cellulose (ORC) fabric, has been developed for adjunctive use in surgical procedures to assist in control of oozing bleeding over broad areas and where access could be difficult with a fabric ORC product. This study compares the new SP to other commercially available hemostatic powder products in two in vivo models.Methods: Hemostatic efficacy of SP was compared to two polysaccharide-based hemostats in a porcine liver punch biopsy model and to three polysaccharide-based hemostats and one non-regenerated oxidized cellulose hemostat in a porcine liver abrasion model. Primary outcomes measured were hemostatic efficacy, defined as hemostasis within 10 minutes of application, and time-to-hemostasis (TTH).Results: In the punch biopsy model, SP displayed significantly higher effective hemostasis rates than one of the polysaccharide hemostats (p=0.047) and faster TTH than both (p<0.001). In the liver abrasion model, SP had significantly higher effective hemostasis rates (p≤0.002) and faster TTH (p<0.001) than the other four hemostatic agents. The amount of powder applied within the ranges used did not appear to affect hemostatic efficacy.Conclusion: In both the liver punch biopsy model of mild to moderate bleeding and the liver abrasion model of mild but diffuse oozing, SP provided more effective hemostasis and faster TTH than other marketed hemostatic powders. The results from this in vivo study suggest that Surgicel Powder may be useful in clinical applications where control of oozing capillary, mild venous, and small arterial hemorrhage is required including bleeding in difficult-to-access locations. Keywords: hemostasis, oxidized regenerated cellulose, Surgicel, in vivo model of bleeding, hemostatic powder, absorbable hemostat, topical absorbable hemostathttps://www.dovepress.com/an-in-vivo-comparison-of-the-efficacy-of-hemostatic-powders-using-two--peer-reviewed-article-MDERhemostasisoxidized regenerated celluloseSURGICELin vivo model of bleedinghemostatic powder
spellingShingle MacDonald MH
Wang AY
Clymer JW
Hutchinson RW
Kocharian R
An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models
Medical Devices: Evidence and Research
hemostasis
oxidized regenerated cellulose
SURGICEL
in vivo model of bleeding
hemostatic powder
title An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models
title_full An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models
title_fullStr An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models
title_full_unstemmed An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models
title_short An in vivo comparison of the efficacy of hemostatic powders, using two porcine bleeding models
title_sort in vivo comparison of the efficacy of hemostatic powders using two porcine bleeding models
topic hemostasis
oxidized regenerated cellulose
SURGICEL
in vivo model of bleeding
hemostatic powder
url https://www.dovepress.com/an-in-vivo-comparison-of-the-efficacy-of-hemostatic-powders-using-two--peer-reviewed-article-MDER
work_keys_str_mv AT macdonaldmh aninvivocomparisonoftheefficacyofhemostaticpowdersusingtwoporcinebleedingmodels
AT wangay aninvivocomparisonoftheefficacyofhemostaticpowdersusingtwoporcinebleedingmodels
AT clymerjw aninvivocomparisonoftheefficacyofhemostaticpowdersusingtwoporcinebleedingmodels
AT hutchinsonrw aninvivocomparisonoftheefficacyofhemostaticpowdersusingtwoporcinebleedingmodels
AT kocharianr aninvivocomparisonoftheefficacyofhemostaticpowdersusingtwoporcinebleedingmodels
AT macdonaldmh invivocomparisonoftheefficacyofhemostaticpowdersusingtwoporcinebleedingmodels
AT wangay invivocomparisonoftheefficacyofhemostaticpowdersusingtwoporcinebleedingmodels
AT clymerjw invivocomparisonoftheefficacyofhemostaticpowdersusingtwoporcinebleedingmodels
AT hutchinsonrw invivocomparisonoftheefficacyofhemostaticpowdersusingtwoporcinebleedingmodels
AT kocharianr invivocomparisonoftheefficacyofhemostaticpowdersusingtwoporcinebleedingmodels